In vivo detection of human vascular endothelial growth factor promoter activity in transgenic mouse skin

American Journal of Pathology

Volumn 157, Issue 1, 2000, Pages 103-110

  Kishimoto, Jiro ^a   Ehama, Ritsuko ^a   Ge, Yimin ^a   Kobayashi, Takashi ^a   Nishiyama, Toshio ^b   Detmar, Michael ^a   Burgeson, Robert E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SHISEIDO RESEARCH CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HAIR FOLLICLE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KERATINOCYTE; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROMOTER REGION; SKIN; SKIN FIBROBLAST; TRANSGENE; TRANSGENIC MOUSE; WOUND HEALING;

EID: 0033883530     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64522-1     Document Type: Article

References (42)

1. Vascular endothelial growth factor (VEGF) and its receptors
2. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
3. Vascular permeability factor (VPF, VEGF) in tumor biology
4. Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice
5. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis
6. Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme
7. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing
8. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing
9. Overexpression of vascular permeability factor/ vascular endothelial growth factor and its receptors in psoriasis
10. Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors
11. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels
12. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker
13. Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation
14. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing
15. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice
16. Molecular regulation of angiogenesis in the skin
17. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice
18. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
19. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
20. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
21. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
22. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes
23. Transcriptional regulation of the rat vascular endothetial growth factor gene by hypoxia
24. Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor
25. The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity
26. Tumor induction of VEGF promoter activity in stromal cells
27. Selective activation of the versican promoter by epithelial-mesenchymal interactions during hair follicle development
28. Primary mouse keratinocyte cultures contain hair tollicle progenitor cells with multiple differentiation potential
29. Reconstitution of hair follicle development in vivo: Determination of follicle formation, hair growth, and hair quality by dermal cells
30. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues macrophages, and tumors
31. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation
32. Multiple developmental roles of VEGF suggested by a LacZ-tagged allele
33. Compston JE: Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage
34. Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression
35. The TGF-beta2 isoform is both a required and sufficient inducer of murine hair follicle morphogenesis
36. Vascular endothelial growth factor is an autocrine growth factor for hair dermal papilla cells
37. Expression of vascular endothelial growth factor (VEGF) in various compartments of the human hair follicle
38. Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells
39. A nuclear GFP that marks nuclei in Wing Drosophila embryos: Maternal supply overcomes a delay in the appearance of zygotic fluorescence
40. Identification of a human VPF/VEGF 3' untranslated region mediating hypoxia-induced mRNA stability
41. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia